Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.920
-0.090 (-2.24%)
At close: Apr 1, 2025, 4:00 PM
3.914
-0.006 (-0.15%)
After-hours: Apr 1, 2025, 7:32 PM EDT

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
5028361,2361,3772,182-
Upgrade
Market Cap Growth
-32.38%-32.38%-10.21%-36.91%--
Upgrade
Enterprise Value
2415739631,0511,806-
Upgrade
Last Close Price
3.926.499.1210.2116.32-
Upgrade
PE Ratio
---534.4941969.36-
Upgrade
Forward PE
35.6426.14-44.39152.95-
Upgrade
PS Ratio
2.554.176.418.3917.06-
Upgrade
PB Ratio
1.282.113.153.245.38-
Upgrade
P/TBV Ratio
2.332.333.493.355.59-
Upgrade
P/FCF Ratio
22.9838.251952.94-8204.54-
Upgrade
P/OCF Ratio
19.7932.94234.09-471.36-
Upgrade
EV/Sales Ratio
1.202.864.996.4114.12-
Upgrade
EV/EBITDA Ratio
--1527.81173.67-
Upgrade
EV/EBIT Ratio
---197.22-
Upgrade
EV/FCF Ratio
11.0426.211522.10-6789.29-
Upgrade
Debt / Equity Ratio
0.040.040.040.04-0.02
Upgrade
Debt / EBITDA Ratio
---4.23-0.19
Upgrade
Debt / FCF Ratio
0.780.7822.33--0.20
Upgrade
Asset Turnover
0.400.400.380.330.380.64
Upgrade
Inventory Turnover
1.701.701.521.551.761.96
Upgrade
Quick Ratio
5.005.005.677.9911.886.91
Upgrade
Current Ratio
5.865.866.979.2613.017.86
Upgrade
Return on Equity (ROE)
-1.53%-1.53%-2.97%0.60%1.04%18.38%
Upgrade
Return on Assets (ROA)
-2.91%-2.91%-3.43%-0.23%1.68%5.88%
Upgrade
Return on Capital (ROIC)
-3.52%-3.52%-4.09%-0.27%1.95%7.98%
Upgrade
Return on Capital Employed (ROCE)
----2.10%7.10%
Upgrade
Earnings Yield
-1.20%-0.72%-0.98%0.19%0.14%-
Upgrade
FCF Yield
4.35%2.61%0.05%-1.60%0.01%-
Upgrade
Buyback Yield / Dilution
3.45%3.45%2.37%-69.93%-150.13%-16.71%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q